O03.6

Clinical Causes: Disorders of blood clotting, such as afibrinogenemia or disseminated intravascular coagulation (DIC), which impair normal blood clot formation Hemolytic reactions leading to destruction of red blood cells, affecting clotting mechanisms Intravascular coagulation syndrome, where blood clots form within blood vessels, consuming clotting factors and leading to bleeding Retained tissue or necrotic material after miscarriage that can trigger abnormal bleeding responses Underlying medical conditions like coagulation factor deficiencies or platelet disorders

Key Symptoms: Profuse or delayed bleeding following miscarriage Bleeding that is disproportionate to the stage of pregnancy loss Signs of anemia such as fatigue, weakness, or pallor due to blood loss Symptoms of underlying clotting disorders, including easy bruising or bleeding from other sites Possible signs of infection if bleeding is associated with retained tissue

Diagnosis Path: Blood tests to evaluate clotting factors, fibrinogen levels, and complete blood count (CBC) Assessment for signs of disseminated intravascular coagulation (DIC), such as elevated D-dimer or decreased platelet count Ultrasound imaging to rule out retained products of conception Histopathological examination if tissue samples are obtained Monitoring of vital signs and blood flow to evaluate severity

Treatment Protocols: Replacement therapy with blood products like fresh frozen plasma, platelets, or cryoprecipitate to restore clotting factors Use of medications such as antifibrinolytics (e.g., tranexamic acid) to reduce bleeding Treating underlying coagulation disorders with specific factor concentrates or medications Supportive care including fluid replacement and transfusions if necessary Addressing any retained tissue or infection through surgical or medical intervention